|
RPS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.959600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.902200E-01 |
| Normal-vs-Stage2 |
3.762200E-01 |
| Normal-vs-Stage3 |
4.200400E-01 |
| Normal-vs-Stage4 |
4.947600E-01 |
| Stage1-vs-Stage2 |
8.623800E-02 |
| Stage1-vs-Stage3 |
9.321200E-01 |
| Stage1-vs-Stage4 |
9.684200E-01 |
| Stage2-vs-Stage3 |
1.335220E-01 |
| Stage2-vs-Stage4 |
1.845230E-01 |
| Stage3-vs-Stage4 |
9.817800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.071600E-01 |
| Normal-vs-AfricanAmerican |
3.035000E-01 |
| Normal-vs-Asian |
4.243400E-01 |
| Caucasian-vs-AfricanAmerican |
1.618640E-01 |
| Caucasian-vs-Asian |
7.282800E-01 |
| AfricanAmerican-vs-Asian |
1.786400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.290400E-01 |
| Normal-vs-Female |
4.978000E-01 |
| Male-vs-Female |
5.746200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.281760E-01 |
| Normal-vs-Age(41-60Yrs) |
6.513800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.087600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.975000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.257200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.038600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.341200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.764600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.439000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.437000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.487400E-01 |
| Classical-VS-Follicular |
8.011600E-01 |
| Classical-VS-Other |
1.829600E-01 |
| Classical-VS-Normal |
4.534800E-01 |
| Tall-VS-Follicular |
7.319200E-01 |
| Tall-VS-Other |
1.777420E-01 |
| Tall-VS-Normal |
6.969200E-01 |
| Follicular-VS-Other |
1.273210E-01 |
| Follicular-VS-Normal |
4.795600E-01 |
| Other-VS-Normal |
1.502570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.705800E-01 |
| Normal-vs-N1 |
6.768600E-01 |
| N0-vs-N1 |
6.183000E-01 |
|
|
